...
首页> 外文期刊>Journal of Medical Virology >Evolution of viral quasispecies in four dominant HlA-A2 restricted T cell epitopes is not a major reason for viral persistence in interferon-treated patients with chronic hepatitis C.
【24h】

Evolution of viral quasispecies in four dominant HlA-A2 restricted T cell epitopes is not a major reason for viral persistence in interferon-treated patients with chronic hepatitis C.

机译:在干扰素治疗的慢性丙型肝炎患者中,四个主要的H1A-A2限制性T细胞表位中的病毒准种的进化不是病毒持久性的主要原因。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In most patients, chronic hepatitis C virus (HCV) infection persists despite antiviral treatment with interferon-alpha (IFN-alpha) and ribavirin. The aim of the study was to determine whether HCV could evade cellular immune responses through mutations within T cell epitopes. Viral sequences flanking four major CTL epitopes within the HCV core and envelope regions were analyzed by PCR amplification, cloning and sequencing in seven HLA-A2 positive HCV patients before, during and after antiviral therapy. In addition, cytotoxic T lymphocyte precursor (CTLp) frequencies specific to these epitopes were quantitated by ELISPOT. A total of 13 coding mutations were observed among 650 cloned and sequenced PCR products under or post IFN treatment but no clear selection of viral variants. In detail, the diversity of quasispecies in the two core epitopes remained fairly stable over time despite variable CTLp induction in some individuals. The overall mutation rate in the two envelope epitopes was higher but there was no correlation with specific CTLp frequencies. In conclusion, although evolution of the viral quasispecies during and after antiviral therapy was demonstrated, immune evasion by epitope specific mutations seemed to be not common in interferon nonresponders because the viral complexity did not increase.
机译:在大多数患者中,尽管使用干扰素-α(IFN-α)和利巴韦林进行抗病毒治疗,慢性丙型肝炎病毒(HCV)感染仍持续存在。该研究的目的是确定HCV是否可以通过T细胞表位内的突变逃避细胞免疫反应。在7名HLA-A2阳性HCV患者抗病毒治疗之前,期间和之后,通过PCR扩增,克隆和测序分析了HCV核心和包膜区域内四个主要CTL表位两侧的病毒序列。另外,通过ELISPOT对这些表位特异的细胞毒性T淋巴细胞前体(CTLp)频率进行了定量。在IFN处理下或之后,在650个克隆和测序的PCR产物中共观察到13个编码突变,但没有明确选择病毒变体。详细地讲,尽管某些个体中CTLp的诱导水平不同,但两个核心表位中准种的多样性随时间保持相当稳定。两个包膜表位的总体突变率较高,但与特定的CTLp频率无关。总之,尽管已证明在抗病毒治疗期间和之后病毒准种的进化,但由于病毒复杂性并未增加,在干扰素无反应者中,表位特异性突变的免疫逃逸似乎并不常见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号